CETICS Healthcare Technologies GmbH

Endorse Company

With its trailblazing analysis technology and digitalization of sample profiles, CETICS ensures a drastic simplification of in-vitro diagnostics (IVD). 

Cost-effective, high-precision infrared spectra are obtained with the patented AquaSpec mid-infrared spectroscopy from biological fluid samples such as blood serum, cerebrospinal fluid, and cell culture supernatant. These spectra contain complex information on the sample components and their concentrations. Each spectrum provides a corresponding snapshot of the individual metabolome and can be digitally saved.